Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	40	non-cytoplasmic
41	60	transmembrane
61	93	cytoplasmic
94	119	transmembrane
120	125	non-cytoplasmic
126	144	transmembrane
145	157	cytoplasmic
158	178	transmembrane
179	201	non-cytoplasmic
202	221	transmembrane
222	232	cytoplasmic
233	256	transmembrane
257	280	non-cytoplasmic
281	310	transmembrane
311	331	cytoplasmic
332	352	transmembrane
353	357	non-cytoplasmic
358	381	transmembrane
382	396	cytoplasmic
397	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	448	cytoplasmic
449	469	transmembrane
470	475	non-cytoplasmic

Input:
>PP_1003
MSEPGQKLRLGALIALVVGSMIGGGIFSLPQNMAARADVGAVLIGWGITAVGMLALAFVF
QTLANRKPELDSGVYAYAKAGFGEYMGFSSAWGYWISAWLGNVGYFVLLFSTLGFYFPVF
GEGNTPIAIGCASLLLWSVHFLVLRGIKEAAFINQVTTVAKVVPLLIFVVIAAFAFRADI
FTRDIWGLSNPQFGSVLEQVRNMMLVTVFVFIGIEGASVYSGRAQRRSDVGKATVIGFLG
VLALLVLVNVLSLGIMTQPELAGLQNPSLASVLEHIVGPWGALLISLGLAVSLLGALLSW
ALLCAEILYATARDKTMPRFLAKENANHVPANALWLTNCMIQGFLLITLFSAGTYTSLIY
LASSMILVPYLWSAAYAVLLAMRAETYAGQPRLRRKDLLVALVALLYAVWLLYAGGLKYL
LLSALLYAPGVILFARAKHEQGQTLFTAWEKLIFAAVLVGAALAAYALYSGLLSL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server